Skip to main content
Equibles
LTRN logo

LTRN · Lantern Pharma Inc.

Track LTRN — free

Use LTRN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about LTRN

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$2.65 +0.02 (+0.76%) At close · Aug 14
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“there is substantial doubt about the Company's ability to continue as a going concern in the absence of obtaining substantial additional funding.”
View the 10-Q filed Aug 14, 2026
Market Cap
$33.88M
Shares
12.78M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2025-05-27 Bios Fund I QP, LP 29,576
2025-05-27 Bios Fund II, LP 53,454
2025-05-27 Bios Fund II QP, LP 105,180
2025-05-27 Bios Fund II NT, LP 25,849
2025-05-27 Bios Fund I, LP 75,941
2024-04-26 Bios Fund II, LP 124,887
2024-04-26 Bios Fund I, LP 371,950
2024-04-26 Bios Fund II NT, LP 54,597
2024-04-26 Bios Fund I QP, LP 217,553
2024-04-26 Bios Fund II QP, LP 407,845
2024-02-28 Bios Fund II NT, LP 13,417
2024-02-28 Bios Fund II QP, LP 100,236
2024-02-28 Bios Fund II, LP 30,650
Showing 1–13 of 13 filings
Key facts CIK 1763950 CUSIP 51654W101 13F (30d) 39 filings 38 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)